InVivo Therapeutics enrolls 7th patient in INSPIRE study: 5 quick points

InVivo Therapeutics enrolled the 7th patient in the INSPIRE study, which is testing the Neuro-Spinal Scaffold implant’s efficacy.

Advertisement

Here are five quick points:

 

1. Charlotte, N.C.-based Carolinas Medical Center enrolled the patient.

 

2. Neurosurgeon Domagoj Coric, MD, implanted the device in the patient about 21 hours post-injury.

 

3. Dr. Coric has implanted the device in three patients.

 

4. The Neuro-Spinal Scaffold is designed to support appositional healing following acute spinal cord injury.

 

5. “This enrollment marks another important step toward completing the INSPIRE study and helping to address this enormous unmet medical need,” said Mark Perrin, CEO and chairman, InVivo.

 

More articles on devices:
DJO Global 2015 net sales hit $308M; Net loss hits $349.9M: 8 things to know
Mesoblast’s Mesenchymal Precursor Cells receives key patent — 5 takeaways
SpineGuard announces full-year 2015 financial results: 9 facts

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.